Search results
Results from the WOW.Com Content Network
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. [8] [9] [10] It is a janus kinase (JAK) inhibitor, [8] [9] discovered and developed by the National Institutes of ...
Drugs developed by Wyeth (31 P) Pages in category "Drugs developed by Pfizer" The following 200 pages are in this category, out of approximately 240 total.
In June 2022, Roivant and Pfizer unveiled Priovant Therapeutics. [22] Priovant was established in September 2021 through a transaction between Roivant and Pfizer, [23] in which Pfizer licensed oral and topical brepocitinib's global development rights and US and Japan commercial rights to Priovant. Pfizer holds a 25% equity ownership interest in ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Pfizer's shares were up 2.6% at $29.30 in afternoon trading. Pfizer made the disclosure on Wednesday in a filing with the Securities and Exchange Commission. Pfizer rolls out another cost-cutting ...
Pfizer Covid pills for symptoms may cause harmful reactions if taken with other prescription medications. ... many people prescribed Pfizer’s or Merck’s new medications will require careful ...
Generally, drugs outlined within the ATC code D should be included in this category. Please see WP:PHARM:CAT for more information. Subcategories.
The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth stra Pfizer lifts profit forecast as CEO sees reason for optimism in 2024 Skip to main ...